Generic and branded pharma companies alike are waiting with baited breath to see if the U.S. Supreme Court will take up the issue of personal jurisdiction in Hatch-Waxman patent cases this term. After a broad ruling from the...more
11/3/2016
/ Abbreviated New Drug Application (ANDA) ,
Brand ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Mylan Pharmaceuticals ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
SCOTUS
One of the worst kept secrets is the experienced and expected growth in healthcare IT. In 2013, over $650 million was invested into healthcare IT companies, and the trend is continuing to grow. Combined with the fact that...more
6/11/2015
/ Apple ,
CLS Bank v Alice Corp ,
Confidentiality Agreements ,
Copyright ,
Google ,
Health Information Technologies ,
Healthcare ,
Information Technology ,
Patents ,
SCOTUS ,
Software ,
Technology ,
Trade Secrets